Simpson Thacher is representing Teleflex Incorporated (NYSE:TFX) in connection with its agreement to acquire privately-held Palette Life Sciences AB (“Palette”) for an upfront cash payment of $600 million at closing, and up to an additional $50 million upon the achievement of certain commercial milestones. The acquisition is subject to customary closing conditions, including receipt of certain regulatory approvals, and is expected to be completed in the fourth quarter of 2023.
Teleflex is a global provider of medical technologies with a diverse portfolio, including solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Palette is a medical device company specializing in the commercialization of injectable gels designed to treat urology ailments.
The Simpson Thacher team includes: Mario Ponce, Ravi Purushotham, Beth DiSciullo, Ngozi Nezianya, Lawrence Page, Isaac Hudis and Peter Simon (M&A); Andrew Purcell, Andrew Mandelbaum and Mohanad Salaimi (Tax); Larry Moss, Ryan Stott (ECEB); Melanie Jolson, Sarika Pandrangi (Privacy); Krista McManus (Real Estate); Peter Guryan, Étienne Renaudeau, Pauline Patat, Daniel Owsley (Antitrust); Michael Isby (Environmental); and Steven DeLott (Insurance).